8:15am ET
Health and Healthcare
Major Biopharma Catalysts on October’s FDA Calendar
Here is a calendar of a few of the biggest companies expecting clinical trial and FDA updates in the month of October.
Companies
Valeant Pharmaceuticals Intern...
$23.40
▼ $0.83 (−3.43%) today
Markets closed · 12:33am ET
Today · % change
VRX Coverage
8:45am ET
Investing
Top Analyst Upgrades and Downgrades: Dollar General, KLA-Tencor, Micron Technology, Nike, Red Hat and More
The top analyst upgrades, downgrades and other research calls from Friday include Bookings Holdings, Dollar General, KLA-Tencor, Micron Technology, Nike and Red Hat.
9:30am ET
Health and Healthcare
Valeant Pharmaceuticals Woes Continue as FDA Fails to Approve Plaque Psoriasis Lotion
Valeant Pharmaceuticals shares were down over 5% in premarket trading Monday after the FDA failed to approve the company's lotion intended to treat plaque psoriasis.
Lee Jackson 8:50am ET
Investing
Top Analyst Upgrades and Downgrades: Alkermes, Cigna, International Paper, Medtronic, Tesla, Western Digital and More
The top analyst upgrades, downgrades and other research calls from Wednesday include Alkermes, Cigna, International Paper, Medtronic, Tesla and Western Digital.
8:55am ET
Investing
Top Analyst Upgrades and Downgrades: CBS, Ford, Pivotal Software, Spotify, Symantec, Ulta Beauty and More
The top analyst upgrades, downgrades and other research calls from Tuesday include CBS, Ford, Pivotal Software, Spotify, Symantec and Ulta Beauty.
10:05am ET
Health and Healthcare
4 Specialty Pharma Stocks That Deutsche Bank Likes for the Rest of 2018
There is deep value for long-term investors in these specialty pharmaceutical companies, and the ability to buy in to some of the best companies in the industry at rock bottom pricing.
9:05am ET
Health and Healthcare
What Will Become of Valeant Pharmaceuticals?
Valeant Pharmaceuticals released its most recent quarterly report and announced a name change before the markets opened on Tuesday.
Chris Lange 10:15am ET
Investing
Disney, Groupon, Nvidia and More Major Earnings Coming This Week
24/7 Wall St. has put together a preview of Disney, Nvidia, Valeant Pharmaceuticals and of some of the other top companies reporting their latest results in the coming week.
8:40am ET
Health and Healthcare
The Top Biopharma Catalysts Coming in May
Here 24/7 Wall St. has included a calendar of some of the biggest companies expecting clinical trial and FDA updates in May.
8:40am ET
Investing
Top Analyst Upgrades and Downgrades: ADM, Boeing, Hess, LogMeIn, NetApp, Sunrun, United Continental, Valeant, XPO and More
The top analyst upgrades, downgrades and other research calls from Friday include Archer Daniels Midland, Boeing, Hess, LogMeIn, NetApp, Sunrun, United Continental, Valeant Pharmaceuticals and XPO Logistics.
8:55am ET
Investing
Deutsche Bank Out With New Top Stock Buys for the Next Year
These six additions to the Deutsche Bank Conviction List are top stocks to buy for the next year for growth accounts looking to add new positions.
1:35pm ET
Health and Healthcare
Does Deutsche Bank Finally Have It Right on Valeant?
Valeant Pharmaceuticals saw its shares make a handy gain on Monday after Deutsche Bank upgraded the stock.
Chris Lange 9:05am ET
Investing
Top Analyst Upgrades and Downgrades: AMAG, Foot Locker, Groupon, H&R Block, McDonald’s, Teradata, Under Armour, Valeant and More
The top analyst upgrades, downgrades and other research calls from Monday include AMAG Pharmaceuticals, Foot Locker, Groupon, H&R Block, McDonald's, Teradata, Under Armour and Valeant Pharmaceuticals.
11:05am ET
Health and Healthcare
Why Valeant Pharmaceuticals Shares Are Backing Way Off
Valeant Pharmaceuticals shares tumbled after it reported its most recent quarterly results early Wednesday.
Chris Lange 10:25am ET
Investing
Square, Salesforce and More Big Earnings to Watch This Week
24/7 Wall St. has put together a preview of Square, Valeant Pharmaceuticals and some of the other top companies reporting their latest results in the coming week.